Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2
- PMID: 12808141
- PMCID: PMC164693
- DOI: 10.1073/pnas.1331358100
Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2
Abstract
Mice lacking the chemokine receptor chemotactic cytokine receptor 2 (CCR2) have a marked attenuation of monocyte recruitment in response to various inflammatory stimuli and a reduction of inflammatory lesions in models of demyelinating disease. In the present study, we compared nociceptive responses in inflammatory and neuropathic models of pain in CCR2 knockout and wild-type mice. In acute pain tests, responses were equivalent in CCR2 knockout and wild-type mice. In models of inflammatory pain, CCR2 knockout mice showed a 70% reduction in phase 2 of the intraplantar formalin-evoked pain response but only a modest (20-30%) and nonsignificant reduction of mechanical allodynia after intraplantar Freund's adjuvant (CFA). In a model of neuropathic pain, the development of mechanical allodynia was totally abrogated in CCR2 knockout mice. CFA administration induced marked up-regulation of CCR2 mRNA in the skin and a moderate increase in the sciatic nerve and dorsal root ganglia (DRG). In response to nerve ligation, persistent and marked up-regulation of CCR2 mRNA was evident in the nerve and DRG. Disruption of Schwann cells in response to nerve lesion resulted in infiltration of CCR2-positive monocytes/macrophages not only to the neuroma but also to the DRG. Chronic pain also resulted in the appearance of activated CCR2-positive microglia in the spinal cord. Collectively, these data suggest that the recruitment and activation of macrophages and microglia peripherally and in neural tissue may contribute to both inflammatory and neuropathic pain states. Accordingly, blockade of the CCR2 receptor may provide a novel therapeutic modality for the treatment of chronic pain.
Figures




Similar articles
-
Mice overexpressing chemokine ligand 2 (CCL2) in astrocytes display enhanced nociceptive responses.Neuroscience. 2007 Nov 9;149(3):706-14. doi: 10.1016/j.neuroscience.2007.08.014. Epub 2007 Aug 14. Neuroscience. 2007. PMID: 17870246
-
Monocyte recruitment and myelin removal are delayed following spinal cord injury in mice with CCR2 chemokine receptor deletion.J Neurosci Res. 2002 Jun 15;68(6):691-702. doi: 10.1002/jnr.10269. J Neurosci Res. 2002. PMID: 12111830
-
Comparison of gene expression profiles in neuropathic and inflammatory pain.J Physiol Pharmacol. 2006 Sep;57(3):401-14. J Physiol Pharmacol. 2006. PMID: 17033093
-
Role of the immune system in neuropathic pain.Scand J Pain. 2019 Dec 18;20(1):33-37. doi: 10.1515/sjpain-2019-0138. Scand J Pain. 2019. PMID: 31730538 Review.
-
Chemokine signaling and the management of neuropathic pain.Mol Interv. 2009 Aug;9(4):188-95. doi: 10.1124/mi.9.4.7. Mol Interv. 2009. PMID: 19720751 Free PMC article. Review.
Cited by
-
RNA-binding protein SYNCRIP contributes to neuropathic pain through stabilising CCR2 expression in primary sensory neurones.Br J Anaesth. 2024 Nov;133(5):1028-1041. doi: 10.1016/j.bja.2024.07.024. Epub 2024 Sep 7. Br J Anaesth. 2024. PMID: 39244479
-
Binding site characterization of G protein-coupled receptor by alanine-scanning mutagenesis using molecular dynamics and binding free energy approach: application to C-C chemokine receptor-2 (CCR2).Mol Divers. 2012 May;16(2):401-13. doi: 10.1007/s11030-012-9368-z. Epub 2012 Apr 22. Mol Divers. 2012. PMID: 22528270
-
Human Mas-related G protein-coupled receptors-X1 induce chemokine receptor 2 expression in rat dorsal root ganglia neurons and release of chemokine ligand 2 from the human LAD-2 mast cell line.PLoS One. 2013;8(3):e58756. doi: 10.1371/journal.pone.0058756. Epub 2013 Mar 7. PLoS One. 2013. PMID: 23505557 Free PMC article.
-
Chemokines and glial cells: a complex network in the central nervous system.Neurochem Res. 2004 May;29(5):1017-38. doi: 10.1023/b:nere.0000021246.96864.89. Neurochem Res. 2004. PMID: 15139300 Review.
-
Comparison of the Effects of Chemokine Receptors CXCR2 and CXCR3 Pharmacological Modulation in Neuropathic Pain Model-In Vivo and In Vitro Study.Int J Mol Sci. 2021 Oct 14;22(20):11074. doi: 10.3390/ijms222011074. Int J Mol Sci. 2021. PMID: 34681732 Free PMC article.
References
-
- Onuffer, J. & Horuk, R. (2002) Trends Pharmacol. Sci. 23, 459-467. - PubMed
-
- Ma, M., Wei, T., Boring, L., Charo, I. F., Ransohoff, R. M. & Jakeman, L. B. (2002) J. Neurosci. Res. 68, 691-702. - PubMed
-
- Siebert, H., Sachse, A., Kuziel, W. A., Maeda, N. & Bruck, W. (2000) J. Neuroimmunol. 110, 177-185. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases